Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Himber

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Methods and Findings in Experimental and Clinical Pharmacology|April 1, 1985
In vitro potential measurement, anaesthetic and antimicrobial effects as indicators of beta-blocker toxicity of the corneaJ Himber, G Andermann, M Erhart, et al.
Thrombosis and Haemostasis|April 20, 2001
Inhibition of arterial thrombosis by a soluble tissue factor mutant and active site-blocked factors IXa and Xa in the guinea pigJ Himber, C J Refino, L Burcklen, et al.
Forensic Science International|July 1, 1988
A specific HPLC method for determination of beta-blockers topically used in ophthalmological diseasesA Tracqui, P Kintz, J Himber, et al.
Journal of Lipid Research|July 1, 1995
Effects of stigmastanyl-phosphocholine (Ro 16-6532) and lovastatin on lipid and lipoprotein levels and lipoprotein metabolism in the hamster on different dietsJ Himber, B Missano, M Rudling, et al.
Journal of Medicinal Chemistry|November 1, 1991
Synthesis and ocular antihypertensive activity of new imidazolidine derivatives containing a beta-blocking side chainD Huber, J D Ehrhardt, N Decker, et al.
Methods and Findings in Experimental and Clinical Pharmacology|May 1, 1989
Beta-adrenoceptor binding potencies of new aliphatic and alicyclic oxime ethers and their relevance to intraocular pressure controlJ Himber, J Velly, P Kintz, et al.
Journal of Ocular Pharmacology|January 1, 1987
Effects of topically applied falintolol: a new beta-adrenergic antagonist for treatment of glaucomaJ Himber, V L Sallee, G Andermann, et al.
Thrombosis and Haemostasis|October 6, 1997
Dissociation of antithrombotic effect and bleeding time prolongation in rabbits by inhibiting tissue factor functionJ Himber, D Kirchhofer, M Riederer, et al.
Journal of Lipid Research|February 1, 1997
Ro 48-8.071, a new 2,3-oxidosqualene:lanosterol cyclase inhibitor lowering plasma cholesterol in hamsters, squirrel monkeys, and minipigs: comparison to simvastatinO H Morand, J D Aebi, H Dehmlow, et al.
Thrombosis and Haemostasis|September 24, 1999
A human antibody that binds to the gamma-carboxyglutamic acid domain of factor IX is a potent antithrombotic in vivoC J Refino, J Himber, L Burcklen, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Methods and Findings in Experimental and Clinical Pharmacology|April 1, 1985
In vitro potential measurement, anaesthetic and antimicrobial effects as indicators of beta-blocker toxicity of the corneaJ Himber, G Andermann, M Erhart, et al.
Thrombosis and Haemostasis|April 20, 2001
Inhibition of arterial thrombosis by a soluble tissue factor mutant and active site-blocked factors IXa and Xa in the guinea pigJ Himber, C J Refino, L Burcklen, et al.
Forensic Science International|July 1, 1988
A specific HPLC method for determination of beta-blockers topically used in ophthalmological diseasesA Tracqui, P Kintz, J Himber, et al.
Journal of Lipid Research|July 1, 1995
Effects of stigmastanyl-phosphocholine (Ro 16-6532) and lovastatin on lipid and lipoprotein levels and lipoprotein metabolism in the hamster on different dietsJ Himber, B Missano, M Rudling, et al.
Journal of Medicinal Chemistry|November 1, 1991
Synthesis and ocular antihypertensive activity of new imidazolidine derivatives containing a beta-blocking side chainD Huber, J D Ehrhardt, N Decker, et al.
Methods and Findings in Experimental and Clinical Pharmacology|May 1, 1989
Beta-adrenoceptor binding potencies of new aliphatic and alicyclic oxime ethers and their relevance to intraocular pressure controlJ Himber, J Velly, P Kintz, et al.
Journal of Ocular Pharmacology|January 1, 1987
Effects of topically applied falintolol: a new beta-adrenergic antagonist for treatment of glaucomaJ Himber, V L Sallee, G Andermann, et al.
Thrombosis and Haemostasis|October 6, 1997
Dissociation of antithrombotic effect and bleeding time prolongation in rabbits by inhibiting tissue factor functionJ Himber, D Kirchhofer, M Riederer, et al.
Journal of Lipid Research|February 1, 1997
Ro 48-8.071, a new 2,3-oxidosqualene:lanosterol cyclase inhibitor lowering plasma cholesterol in hamsters, squirrel monkeys, and minipigs: comparison to simvastatinO H Morand, J D Aebi, H Dehmlow, et al.
Thrombosis and Haemostasis|September 24, 1999
A human antibody that binds to the gamma-carboxyglutamic acid domain of factor IX is a potent antithrombotic in vivoC J Refino, J Himber, L Burcklen, et al.
Pageof 3